Self-control – once more about the most important things
https://doi.org/10.21518/2079-701X-2016-17-138-142
Abstract
Diabetes mellitus (DM) is a complex disease the key component of which is dysglycemia leading to development of late complications. The necessary condition to achieve the glycemic control in conditions of day-to-day life is blood glucose selfcontrol. But for the team doctor-patient determination of the self-control aim is not a simple task. For its solution a variety of randomized controlled studies were conducted and their analysis provoked a number of new issues. The indisputable fact is that self-control helps in achievement of the long-term glycemic control in patients of DM2, contributes to prevention of acute and late diabetic complications development.
About the Authors
T. A. Meleshkevich
Semashko Central Clinical Hospital No. 2 of RZD OJSC, Federal Bureau of Medical and Social Expertise
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
M. E. Shevchenko
Semashko Central Clinical Hospital No. 2 of RZD OJSC, Federal Bureau of Medical and Social Expertise
Russian Federation
Russian Federation
E. I. Luchina
Semashko Central Clinical Hospital No. 2 of RZD OJSC, Federal Bureau of Medical and Social Expertise
Russian Federation
Russian Federation
P. S. Popov
Semashko Central Clinical Hospital No. 2 of RZD OJSC, Federal Bureau of Medical and Social Expertise
Russian Federation
Russian Federation
G. A. Slonimskaya
Semashko Central Clinical Hospital No. 2 of RZD OJSC, Federal Bureau of Medical and Social Expertise
Russian Federation
Russian Federation
References
1. Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 7-й выпуск, 2015.
2. Дедов И.И, Шестакова М.В. Значимость результатов исследования ADVANCE для контроля сахарного диабета в России. Сахарный диабет, 2009, 2: 4-5.
3. Майоров А.Ю. Комментарии к Руководству Международной Диабетической Федерации по контролю постпрандиальной гликемии. Сахарный диабет, 2008, 2: 84-85.
4. Зубкова С.Т. Гипогликемия как фактор риска сердечно-сосудистых нарушений у больных сахарным диабетом 2 типа. Здоровье Украины, 2012.
5. Петров А.В. Самоконтроль гликемии при сахарном диабете – основные принципы планирования и обзор клинических рекомендаций. Поликлиника, 2014, 4.
6. Подачина С.В. Обучение больных сахарным диабетом. Самоконтроль глюкозы крови. Медицинский совет 2013, 5.
7. Климонтов В.В., Мякина Н.Е. Вариабельность гликемии при сахарном диабете: инструмент для оценки качества гликемического контроля и риска осложнений. Сахарный диабет, 2014, (2): 76-82.
8. Polonsky WH, Fisher L, Shikman CH, Hinnen DA, Parkin GC, Jelsovsky Z et al. Structured SMBG significantly reduces HbA1c levels in poorlycontrolled, non-insulin treated type 2 Diabetes: Results from the STeP Study [NCT00674986]. Diabetes Care, 2011 February, 34: 262-267. doi:10.2337/dc10-1732.
9. Welschen LMC, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WAB et al. Selfmonitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Diabetes Care, 2005, 28: 1510-7.
10. Parkin CG, Hinnen DA, Tetrick DL. Effective use of structured self-management of blood glucose in type 2 diabetes: lessons from the STeP study. Clin Diabetes, 2011, 29(4): 131-8.
11. Allemann S, Houriet C, Diem P, Stettler C. Selfmonitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Curr Med Res Opin, 2009, 25(12): 2903-13.
12. Peel E, Parry O, Douglas M, Lawton J. Blood glucose self-monitoring in non-insulin-treated type 2 diabetes: a qualitative study of patients’ perspectives. Br J Gen Pract, 2004, 54(500): 183-8.
13. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ et al. Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC), European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J, 2007, 28(1): 88-136.
14. Kleefstra N, Hortensius J, Logtenberg SJ, Slingerland RJ, Groenier KH, Houweling ST, Gans RO, van Ballegooie E, Bilo HJ. Selfmonitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC). Neth J Med, 2010, 68(1): 311-6.
15. Farmer A, Wade A, French DP, Goyder E, Kinmonth AL, Neil A. The DiGEM trial protocol– a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]. BMC Fam Pract, 2005, 6: 25.
16. Self-monitoring of blood glucose in non-insulin treated type 2 diabetes. IDF guideline. 2009.
17. Caswell M et al: Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System. Diabetes Technol Ther, 2015, 3: 1-7.
18. Holman R, Paul S, Bethel M. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med., 2008, 359, 15: 1577-1589.
19. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev, 2007, 87, 4: 1409-1439.
20. Листовка – вкладыш к тест-полоскам Contour Plus (Контур Плюс) РУ №РЗН 2015/2584 от 28.04.2015.
Review
For citations:
Meleshkevich TA, Shevchenko ME, Luchina EI, Popov PS, Slonimskaya GA. Self-control – once more about the most important things. Meditsinskiy sovet = Medical Council. 2016;(17):138-142. (In Russ.) https://doi.org/10.21518/2079-701X-2016-17-138-142
Views:
614
Email this article 